Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Higashio

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 2, 1998
[Osteoclastogenesis inhibitory factor (OCIF)/OPG]E Tsuda, K Higashio
EXS|January 1, 1993
Tumor cytotoxic activity of HGF-SFK Higashio, N Shima
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 1, 1992
[Structure and biological property of fibroblast-derived tumor cytotoxic factor (F-TCF)]N Shima, K Higashio
Biochimica Et Biophysica Acta|January 13, 1992
Possible roles of arachidonic acid and its metabolites in induction of tissue plasminogen activator (t-PA) production in human fibroblast, IMR-90 cells by proteose peptoneA Suzuki, S Mitsuda, K Higashio, et al.
International Journal of Biological Macromolecules|October 20, 1998
Natural hepatocyte growth factor (HGF) from human serum and a bound form of recombinant HGF with heparan sulfate are indistinguishable in their physicochemical propertiesK Yano, E Tsuda, M Ueda, et al.
Thrombosis Research|October 15, 1991
Participation of phospholipase A2 in induction of tissue plasminogen activator (t-PA) production by human fibroblast, IMR-90 cells, stimulated by proteose peptoneA Suzuki, S Mitsuda, K Higashio, et al.
Gastroenterologia Japonica|August 1, 1991
ELISA for F-TCF (human hepatocyte growth factor/hHGF)/fibroblast-derived tumor cytotoxic factor antigen employing monoclonal antibodies and its application to patients with liver diseasesN Shima, K Higashio, H Ogaki, et al.
Journal of Pharmaceutical Sciences|January 6, 1999
Effective administration route for the deleted form of hepatocyte growth factor To exert its pharmacological effectsY Uematsu, N Fujise, K Kohsaka, et al.
Journal of Bone and Mineral Metabolism|October 31, 2001
Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factorK Yano, N Nakagawa, H Yasuda, et al.
Molecular and Cellular Biology|December 1, 1991
A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingersT Morinaga, H Yasuda, T Hashimoto, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 2, 1998
[Osteoclastogenesis inhibitory factor (OCIF)/OPG]E Tsuda, K Higashio
EXS|January 1, 1993
Tumor cytotoxic activity of HGF-SFK Higashio, N Shima
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 1, 1992
[Structure and biological property of fibroblast-derived tumor cytotoxic factor (F-TCF)]N Shima, K Higashio
Biochimica Et Biophysica Acta|January 13, 1992
Possible roles of arachidonic acid and its metabolites in induction of tissue plasminogen activator (t-PA) production in human fibroblast, IMR-90 cells by proteose peptoneA Suzuki, S Mitsuda, K Higashio, et al.
International Journal of Biological Macromolecules|October 20, 1998
Natural hepatocyte growth factor (HGF) from human serum and a bound form of recombinant HGF with heparan sulfate are indistinguishable in their physicochemical propertiesK Yano, E Tsuda, M Ueda, et al.
Thrombosis Research|October 15, 1991
Participation of phospholipase A2 in induction of tissue plasminogen activator (t-PA) production by human fibroblast, IMR-90 cells, stimulated by proteose peptoneA Suzuki, S Mitsuda, K Higashio, et al.
Gastroenterologia Japonica|August 1, 1991
ELISA for F-TCF (human hepatocyte growth factor/hHGF)/fibroblast-derived tumor cytotoxic factor antigen employing monoclonal antibodies and its application to patients with liver diseasesN Shima, K Higashio, H Ogaki, et al.
Journal of Pharmaceutical Sciences|January 6, 1999
Effective administration route for the deleted form of hepatocyte growth factor To exert its pharmacological effectsY Uematsu, N Fujise, K Kohsaka, et al.
Journal of Bone and Mineral Metabolism|October 31, 2001
Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factorK Yano, N Nakagawa, H Yasuda, et al.
Molecular and Cellular Biology|December 1, 1991
A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingersT Morinaga, H Yasuda, T Hashimoto, et al.
Pageof 7